R. Bascom, K. Hitz, Anne E. F. Dimmock, M. Makhay, K. Matsuda
{"title":"一项评估MN-001(替鲁司特)在特发性肺纤维化患者中的疗效、安全性和耐受性的单中心、随机、安慰剂对照研究","authors":"R. Bascom, K. Hitz, Anne E. F. Dimmock, M. Makhay, K. Matsuda","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1898","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"26 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Single-Center, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of MN-001 (Tipelukast) in Subjects with Idiopathic Pulmonary Fibrosis\",\"authors\":\"R. Bascom, K. Hitz, Anne E. F. Dimmock, M. Makhay, K. Matsuda\",\"doi\":\"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1898\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":333033,\"journal\":{\"name\":\"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD\",\"volume\":\"26 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1898\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1898","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A Single-Center, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of MN-001 (Tipelukast) in Subjects with Idiopathic Pulmonary Fibrosis